NRSN — NEUROSENSE THERAPEUTICS LTD
As of Q2 2026, 3 SEC-registered investment managers reported holding NRSN (NEUROSENSE THERAPEUTICS LTD) in their latest 13F filings, with a combined reported value of $104.87K across 145.66K shares. That is +11.6% by share count (+15.10K shares) versus the previous quarter, while reported value moved +6.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
NRSN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 108.64K | $78.22K | 0.00% | Add |
| PNC Financial Services history | 21.15K | $15.23K | 0.00% | Hold |
| Geode Capital Management history | 15.87K | $11.43K | 0.00% | Hold |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 49.10K | $37.07K | 0.00% | Add |
| Two Sigma Investments history | 44.45K | $33.56K | 0.00% | Reduce |
| PNC Financial Services history | 21.15K | $15.97K | 0.00% | New |
| Geode Capital Management history | 15.87K | $11.98K | 0.00% | Hold |
Q4 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Two Sigma Investments history | 51.55K | $39.64K | 0.00% | Add |
| UBS Group AG history | 30.87K | $23.74K | 0.00% | Add |
| Geode Capital Management history | 15.87K | $12.20K | 0.00% | Hold |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 66.40K | $83.00K | 0.00% | Reduce |
| Two Sigma Investments history | 21.09K | $26.36K | 0.00% | New |
| Geode Capital Management history | 15.87K | $19.84K | 0.00% | Hold |
| UBS Group AG history | 14.66K | $18.32K | 0.00% | Add |
Q2 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 149.24K | $282.07K | 0.00% | New |
| Morgan Stanley history | 79.90K | $151.01K | 0.00% | Add |
| Geode Capital Management history | 15.87K | $29.99K | 0.00% | Hold |
| Marshall Wace history | 11.83K | $22.36K | 0.00% | New |
| UBS Group AG history | 1.61K | $3.04K | 0.00% | Reduce |
Q1 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 50.50K | $46.96K | 0.00% | Reduce |
| Geode Capital Management history | 15.87K | $14.60K | 0.00% | Hold |
| UBS Group AG history | 2.27K | $2.12K | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Two Sigma Investments sold 44.45K sh · $33.56K
Fund Position History — shares by quarter (top 12 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 108.64K | 49.10K | 30.87K | 14.66K | 1.61K | 2.27K | — | — | — | 11.93K | 5.50K | 9.66K | — | 4.76K | 4.07K | 1.83K | 13.43K | 1.88K | 8.02K |
| PNC Financial Services | 21.15K | 21.15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 15.87K | 15.87K | 15.87K | 15.87K | 15.87K | 15.87K | 15.87K | 11.96K | 11.96K | 11.96K | 11.96K | — | — | — | — | — | — | — | — |
| Morgan Stanley | — | — | — | 66.40K | 79.90K | 50.50K | 102.58K | — | 1.50K | 1.50K | 1.50K | — | — | — | 4 | 4 | — | — | — |
| Two Sigma Investments | — | 44.45K | 51.55K | 21.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | 149.24K | — | 254.00K | 34.28K | — | — | — | 11.70K | — | — | — | — | — | — | 55.12K |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | 100.00K | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | 1.30K | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | 71.10K | — | — | — | — | 18.43K | 54.30K | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 49.74K | 10 | — |
| Marshall Wace | — | — | — | — | 11.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 20.26K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details